Press "Enter" to skip to content

New patent for Bausch drug ZYCLARA

1
Copyright © DrugPatentWatch. Originally published at New patent for Bausch drug ZYCLARA

Annual Drug Patent Expirations for ZYCLARA
Annual Drug Patent Expirations for ZYCLARA

Zyclara is a drug marketed by Bausch and is included in one NDA. It is available from two suppliers. There are six patents protecting this drug and two Paragraph IV challenges.

ZYCLARA drug price trends.

This drug has fifty-one patent family members in thirty-one countries.

The generic ingredient in ZYCLARA is imiquimod. Two suppliers are listed for this compound. Additional details are available on the imiquimod profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Bausch drug ZYCLARA

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions